Search

Author/Creator Lipkowitz, Stanley

1. A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses. Issue 1 (25th July 2019)

Authors:
Zimmer, Alexandra S.; Nichols, Erin; Cimino-Mathews, Ashley; Peer, Cody; Cao, Liang; Lee, Min-Jung; Kohn, Elise C.; Annunziata, Christina M.; Lipkowitz, Stanley; Trepel, Jane B.; Sharma, Rajni; Mikkilineni, Lekha; Gatti-Mays, Margaret; Figg, William D.; Houston, Nicole D.; Lee, Jung-Min
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib (LY2606368) in BRCA Wild‐Type, Advanced Triple‐Negative Breast Cancer. (24th June 2020)

Authors:
Gatti‐Mays, Margaret E.; Karzai, Fatima H.; Soltani, Sanaz N.; Zimmer, Alexandra; Green, Jeffrey E.; Lee, Min‐Jung; Trepel, Jane B.; Yuno, Akira; Lipkowitz, Stanley; Nair, Jayakumar; McCoy, Ann; Lee, Jung‐Min
Journal:
Oncologist
Issue:
Volume 25:Number 12(2020)
Page Start:
1013
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Characterization of TR‐107, a novel chemical activator of the human mitochondrial protease ClpP. Issue 4 (5th August 2022)

Authors:
Fennell, Emily M. J.; Aponte‐Collazo, Lucas J.; Wynn, Joshua D.; Drizyte‐Miller, Kristina; Leung, Elisa; Greer, Yoshimi Endo; Graves, Paul R.; Iwanowicz, Andrew A.; Ashamalla, Hani; Holmuhamedov, Ekhson; Lang, Henk; Karanewsky, Donald S.; Der, Channing J.; Houry, Walid A.; Lipkowitz, Stanley; Iwa...
Journal:
Pharmacology research & perspectives
Issue:
Volume 10:Issue 4(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Late‐onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma. Issue 9 (20th April 2022)

Authors:
Modlin, Emily W.; Slavotinek, Anne M.; Darling, Thomas N.; Lipkowitz, Stanley; Barr, Frederic G.; Munster, Pamela N.; Biesecker, Leslie G.; Ours, Christopher A.
Journal:
American journal of medical genetics
Issue:
Volume 188:Issue 9(2022)
Page Start:
2766
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study. Issue 2 (February 2018)

Authors:
Lee, Jung-Min; Nair, Jayakumar; Zimmer, Alexandra; Lipkowitz, Stanley; Annunziata, Christina M; Merino, Maria J; Swisher, Elizabeth M; Harrell, Maria I; Trepel, Jane B; Lee, Min-Jung; Bagheri, Mohammad H; Botesteanu, Dana-Adriana; Steinberg, Seth M; Minasian, Lori; Ekwede, Irene; Kohn, Elise C
Journal:
Lancet oncology
Issue:
Volume 19:Issue 2(2018)
Page Start:
207
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗